J Clin Endocrinol Metab 103(1):288294
In addition to using medications to facilitate weight loss, we may also recommend lifestyle changes
Davies, LixiLan-O Trial Investigators, Benefits of LixiLan, a titratable fixed-ratio combination of insulin Glargine plus Lixisenatide, versus insulin Glargine and Lixisenatide monocomponents in type 2 diabetes inadequately controlled on oral agents: The LixiLan-O randomized trial
Your Hashimoto's will continue to require the same immune management regardless of GLP-1 use
These types of medications can help manage blood sugar levels, however early research is showing GLP-1 and anesthesia can create adverse complications for the patient
However, RYGB did not reverse hyperglycaemia or increase -cell activity in older diabetic mice or mice with chemical ablation of -cells 63